ENvue Medical amends 2024 Long Term Incentive Plan for Israeli tax compliance and name change

ENvue Medical, Inc.

Board approved amended and restated 2024 Long Term Incentive Plan on December 24, 2025.
Adds restricted stock units under Section 102 for Israeli tax compliance; other non-material updates.
Reflects company name change from NanoVibronix to ENvue Medical and prior stockholder-approved amendment.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.